semaglutide oral obesity FDA Approves Semaglutide: First GLP-1 Weight Loss Pill Everything You Need To Know

Lorenzo Leggio, a National Institute on Drug Abuse clinical director who wasnt involved in the study

Although both medications are injectable treatments, they are not the same and are prescribed for different primary purposes

Another important difference lies in the interpretation of risk and benefit

At the end of the day, we want you to enjoy what you love

Ozempic Isn't Even Approved for General Weight Loss While Ozempic is probably the most well-known GLP-1, it isn't technically even approved for general weight loss

The flat-rate pricing for compounded medications may be advantageous for some patients, particularly those requiring higher doses